External validation of risk scores for major bleeding in a population-based cohort of transient ischemic attack and ischemic stroke patients
<strong>Background and Purpose—</strong>The S2TOP-BLEED score may help to identify patients at high risk of bleeding on antiplatelet drugs after a transient ischemic attack or ischemic stroke. The score was derived on trial populations, and its performance in a real-world setting is unkn...
主要な著者: | Hilkens, N, Li, L, Rothwell, P, Algra, A, Greving, J |
---|---|
フォーマット: | Journal article |
出版事項: |
American Heart Association
2018
|
類似資料
-
Refining prediction of major bleeding on antiplatelet treatment after transient ischaemic attack or ischaemic stroke
著者:: Hilkens, NA, 等
出版事項: (2020) -
Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke
著者:: Hilkens, N, 等
出版事項: (2018) -
Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke.
著者:: Rothwell, P, 等
出版事項: (2004) -
External Validation of the Nelson Equation for Kidney Function Decline in Patients with Acute Ischemic Stroke or Transient Ischemic Attack
著者:: Zhou H, 等
出版事項: (2023-06-01) -
Low Remnant Cholesterol and In‐Hospital Bleeding Risk After Ischemic Stroke or Transient Ischemic Attack
著者:: Zhiyuan Wu, 等
出版事項: (2024-07-01)